Aggressive progression of breast cancer with microscopic pulmonary emboli possessing a stem cell‐like phenotype independent of its origin

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Pathology international (Print)

• Publication date

  2010-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1440-1827.2009.02502.xPMID 20403050
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer stem cells in breast cancer and metastasis

  2009cited by this paper
• Stem cell marker aldehyde dehydrogenase 1‐positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression

  2009cited by this paper
• Hypoxia and pluripotency in embryonic and embryonal carcinoma stem cell biology.

  2009cited by this paper
• Embryonic stem cell markers expression in cancers.

  2009cited by this paper
• Identification of selective inhibitors of cancer stem cells by high-throughput screening.

  2009cited by this paper
• Pattern of metastatic spread in triple-negative breast cancer

  2009cited by this paper
• The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype

  2009cited by this paper
• Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells

  2009cited by this paper
• Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

  2009cited by this paper
• Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1

  2008cited by this paper
• Hyaluronan-CD44 Interaction Activates Stem Cell Marker Nanog, Stat-3-mediated MDR1 Gene Expression, and Ankyrin-regulated Multidrug Efflux in Breast and Ovarian Tumor Cells*

  2008cited by this paper
• An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors

  2008cited by this paper
• "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management.

  2008cited by this paper
• The lymphovascular embolus of inflammatory breast cancer expresses a stem cell-like phenotype.

  2008cited by this paper
• Transitions between epithelial and mesenchymal states in development and disease.

  2008cited by this paper
• ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

  2007cited by this paper
• Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors

  2007cited by this paper
• Triple negative tumours: a critical review

  2007cited by this paper
• Stem Cell Origin of Death-from-Cancer Phenotypes of Human Prostate and Breast Cancers

  2007cited by this paper
• Prognostic markers in triple‐negative breast cancer

  2007cited by this paper
• Concordance among gene-expression-based predictors for breast cancer.

  2006cited by this paper
• Most Early Disseminated Cancer Cells Detected in Bone Marrow of Breast Cancer Patients Have a Putative Breast Cancer Stem Cell Phenotype

  2006cited by this paper
• Cancer stem cells: an old idea--a paradigm shift.

  2006cited by this paper
• Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

  2005cited by this paper
• Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

  2004cited by this paper
• Prospective identification of tumorigenic breast cancer cells

  2003cited by this paper
• Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas

  2003cited by this paper
• An Intact Overexpressed E-cadherin/α,β-Catenin Axis Characterizes the Lymphovascular Emboli of Inflammatory Breast Carcinoma

  2001cited by this paper
• An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma.

  2001cited by this paper
• A novel human xenograft model of inflammatory breast cancer.

  1999cited by this paper
• Microscopic pulmonary tumor embolism causing subacute cor pulmonale: a difficult antemortem diagnosis.

  1991cited by this paper
• Acute cor pulmonale resulting from tumor microembolism.

  1980cited by this paper

• Long-Chain Fatty Acids Alter Estrogen Receptor Expression in Breast Cancer Cells

  2025cites this paper
• Pulmonary tumor embolism: A retrospective study over a 30-year period

  2021cites this paper
• Microscopic pulmonary tumor embolism from adenocarcinoma of the prostate

  2020cites this paper
• from an initial diagnosis of pulmonary thromboembolic disease to a pulmonary tumor thrombotic microangiopathy consideration

  2018cites this paper
• Pulmonary Tumor Embolism 18 Years after Surgery for Paget's Disease of the Breast

  2017cites this paper
• Visualization of early prostatic adenocarcinoma as a stem cell disease

  2016cites this paper
• Fatal microscopic pulmonary tumour embolisms in patients with breast cancer: necessary knowledge for future medical practice.

  2014cites this paper
• A Case Report of Breast Cancer with Extensive Pulmonary Lymphovascular Tumor Emboli

  2012cites this paper
• Biomarkers of Cancer Stem Cells

  2012cites this paper
• STUDIES ON EVALUATION OF STEM CELL LINEAGE IN CANINE MAMMARY TUMOR

  2011cites this paper